Noticias de LLY_US
Noticias del mercado
Últimas noticias sobre LLY_US — 1345 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Eli Lilly (NYSE:LLY) is in focus after a verified corporate update, while sector conditions and broader market themes shape discussion around its operating current direction.
Stockholders approved AtaiBeckley’s merger agreement with Eli Lilly after a 65.6% quorum; closing is expected Sept. 11, 2026, if conditions are met.
Moonwalk Biosciences has raised an oversubscribed $70 million Series B financing to advance its pipeline of adipose-targeted RNA interference medicines for obesity and cardiometabolic diseases. The round was co-led by Alpha Wave and YK Bioventures, with participation from Eli Lilly and Company, Gaorong Ventures, ARCH Venture Partners, Khosla Ventures and Future Ventures.
During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start.
The latest trading day saw Eli Lilly (LLY) settling at $1, representing a -2.21% change from its previous close.
The big story today with Eli Lilly is its hugely successful GLP-1 drugs, but the long-term story is likely to be about its acquisitions.
Página 36 de 68